Investors Catching Stocks Castlight Health, inc.(NYSE:CSLT): NeoGenomics, Inc.(NASDAQ:NEO)

0
4
touch screen graph on tablet

Castlight Health, inc. (CSLT) will report its next earnings on Oct 24 AMC. The company reported the earnings of $-0.04/Share in the last quarter where the estimated EPS by analysts was $-0.01/share. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -300%.

Many analysts are providing their Estimated Earnings analysis for Castlight Health, inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-0.02/share. These analysts have also projected a Low Estimate of $-0.04/share and a High Estimate of $-0.01/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Castlight Health, inc. as 35.24 Million. According to these analysts, the Low Revenue Estimate for Castlight Health, inc. is 34.06 Million and the High Revenue Estimate is 37.1 Million. The company had Year Ago Sales of 42.1 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CSLT to be -400%. They are projecting Next Quarter growth of -33.33%. For the next 5 years, Castlight Health, inc. is expecting Growth of 36.36% per annum, whereas in the past 5 years the growth was -22.22% per annum.

Some buy side analysts are also providing their Analysis on Castlight Health, inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Castlight Health, inc. might touch $7 high while the Average Price Target and Low price Target is $3.46 and $1.75 respectively.

Castlight Health, inc. closed its last trading session at $1.56 with the loss of -3.21%. The Market Capitalization of the company stands at 219.36 Million. The Company has 52-week high of $4.15 and 52-week low of $1.21. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.14% where SMA50 and SMA200 are 3.25% and -44.71% respectively. The Company Touched its 52-Week High on 03/14/19 and 52-Week Low on 10/08/19.

The Relative Volume of the company is 5.6 and Average Volume (3 months) is 657.53 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -13.9%. The Return on Equity (ROE) value stands at -18.8%. While it’s Return on Investment (ROI) value is -20.1%.

While looking at the Stock’s Performance, Castlight Health, inc. currently shows a Weekly Performance of -5.63%, where Monthly Performance is 20.8%, Quarterly performance is -10.65%, 6 Months performance is -60.05% and yearly performance percentage is -37.34%. Year to Date performance value (YTD perf) value is -30.41%. The Stock currently has a Weekly Volatility of 7.65% and Monthly Volatility of 6.71%.

NeoGenomics, Inc. (NEO) will report its next earnings on Oct 29 BMO. The company reported the earnings of $0.07/Share in the last quarter where the estimated EPS by analysts was $0.06/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 16.7%.

Many analysts are providing their Estimated Earnings analysis for NeoGenomics, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $0.06/share. These analysts have also projected a Low Estimate of $0.05/share and a High Estimate of $0.09/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for NeoGenomics, Inc. as 104.02 Million. According to these analysts, the Low Revenue Estimate for NeoGenomics, Inc. is 102.39 Million and the High Revenue Estimate is 106.1 Million. The company had Year Ago Sales of 76.47 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for NEO to be 0%. They are projecting Next Quarter growth of 0%. For the next 5 years, NeoGenomics, Inc. is expecting Growth of 30.77% per annum, whereas in the past 5 years the growth was 30% per annum.

Some buy side analysts are also providing their Analysis on NeoGenomics, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for NeoGenomics, Inc. might touch $31 high while the Average Price Target and Low price Target is $28.57 and $26 respectively.

NeoGenomics, Inc. closed its last trading session at $23.22 with the loss of -1.25%. The Market Capitalization of the company stands at 2.38 Billion. The Company has 52-week high of $26.89 and 52-week low of $11.05. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 12.83% where SMA50 and SMA200 are 5.95% and 7.92% respectively. The Company Touched its 52-Week High on 08/19/19 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.97 and Average Volume (3 months) is 843.65 million. The company’s P/E (price to earnings) ratio is 1146.5 and Forward P/E ratio of 66.46.

The company shows its Return on Assets (ROA) value of 0.4%. The Return on Equity (ROE) value stands at 0.5%. While it’s Return on Investment (ROI) value is 2%.

While looking at the Stock’s Performance, NeoGenomics, Inc. currently shows a Weekly Performance of 14.94%, where Monthly Performance is 18.32%, Quarterly performance is -9.8%, 6 Months performance is -1.38% and yearly performance percentage is 29.47%. Year to Date performance value (YTD perf) value is 81.84%. The Stock currently has a Weekly Volatility of 4.92% and Monthly Volatility of 3.62%.

SHARE